Skip to main content


Open for Submissions

Cancer-associated fibroblasts

Guest Editors
Lukas Lacina, MD, PhD, Charles University, Czech Republic 
Karel Smetana, Jr., DrSc, MUDr, Charles University, Czech Republic 

Submission Status: Open until 13 March 2025

Cancer vaccines

Guest Editors
Chunlin Ou, PhD, Central South University, China
Leonardo O. Reis, MD, MSc, PhD, Pontifical Catholic University of Campinas and State University of Campinas, Brazil 

Submission Status: Open until 7 March 2025

Quality of life and supportive care in cancer

Guest Editors
Eileen Shinn, PhD, University of Texas MD Anderson Cancer Center, USA

Christina Signorelli, PhD, UNSW Sydney, Australia 

Submission Status: Open until 28 February 2025

Hereditary cancer syndromes

Guest Editors
Daniele Fanale, PhD, University of Palermo, Italy
Mev Domínguez Valentin, PhD, Oslo University Hospital, Norway
Ling Zhang, MD, H Lee Moffitt Cancer Center and Research Institution, USA

Submission Status: Open until 22 February 2025

Racial and ethnic disparities in cancer care

Guest Editors
Shakira Grant, MBBS, MSCR, American Society of Hematology/American Association for the Advancement of Science (ASH/AAAS) Science and Technology Policy Fellowships, USA
Gregory Vidal, MD, PhD, West Cancer Center Research Institute, USA

Submission Status: Open until 21 February 2025

Challenges and advances in brain tumor diagnosis and treatment

Guest Editors
Antonella Castellano, MD, PhD, Vita-Salute San Raffaele University and Ospedale San Raffaele, Italy 
Mustafa Aziz Hatiboglu, MD, Bezmialem Vakif University, Türkiye 
Imran Khan, PhD, University of Nebraska Center, US

Submission Status: Open until 30 January 2025

Cancer therapy: KRAS targeted therapies

Guest Editors
Biswarup Saha, MS, MTech, PhD, H Lee Moffitt Cancer Center & Research Institute, USA
Hitendra Singh Solanki, PhD, H. Lee Moffitt Cancer Center, USA

Submission Status: Open until 21 November 2024

Hyperthermia therapy for cancer

Guest Editors
Arlene Oei, PhD, Amsterdam University Medical Center, The Netherlands
Tan Hwei Ching Grace, MBBS, MRCS, MMED, FRCS, Melissa Teo Surgery and The Surgical Oncology Clinic, Singapore

Submission Status: Open until 8 November 2024

Rare cancers

Guest Editors
Atif A. Ahmed, MD, University of Washington, Seattle Children’s Hospital, USA
Bruna Samia Dalmasso, MD, PhD, Genetics of Rare Cancers, IRCCS Ospedale Policlinico San Martino, Italy

Submission Status: Open until 6 September 2024

Viral carcinogenesis

Guest Editor
Julian Naipauer, PhD, Instituto de Fisiología, Biología Molecular y Neurociencias, Argentina

Submission Status: Open until 20 August 2024

Applications of ctDNA and liquid biopsies in precision oncology

Guest Editors
Claude Chelala, PhD, Queen Mary University of London, UK
Pasquale Pisapia, PhD, University of Naples Federico II, Italy

Submission Status: Open until 24 July 2024


Altered DNA repair mechanism in tumorigenesis

Guest Editors
Kiyohiro Ando, MD, PhD, Saitama Cancer Center, Research Institute for Clinical Oncology, Japan
Pietro Di Fazio, PhD, Department of Visceral, Thoracic and Vascular Surgery, Philipps University Marburg, Germany
Zhihua Kang, PhD, Rutgers Cancer Institute of New Jersey, USA

Overcoming therapy resistance in prostate cancer

Guest Editors
Holger Erb, PhD: Dresden University of Technology, Germany
Jacob Orme, MD, PhD: Mayo Clinic, USA

Radiomics in cancer diagnosis and treatment

Guest Editors
Archya Dasgupta, MD: Tata Memorial Centre, Homi Bhabha National Institute, India
Qingtao Qiu, MD: Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, China
Stefania Volpe, MD, PhD: European Institute of Oncology (Istituto Europeo di Oncologia, IEO) IRCCS and University of Milan, Italy

Cancer stem cells in the tumor microenvironment

Guest Editors
Liang Qiao: Westmead Institute for Medical Research and The University of Sydney, Australia
Jenny Y. Wang: University of Sydney and Kolling Institute, Australia

Diet and physical activity during and after cancer treatment

Guest Editors
Nicolas H. Hart: University of Technology Sydney, Australia
Dominic O’Connor: University of Nottingham, UK

Immunology and immunotherapy in solid cancers

Guest Editors
Zachary C. Hartman: Duke University, USA
Daniel Smrz: Charles University and Motol University Hospital, Czech Republic

Advances in personalized radiotherapy

Guest Editors:
Venkata SK. Manem: University of Quebec at Trois-Rivières, Canada
Farzad Taghizadeh-Hesary: Iran University of Medical Sciences, Iran

New breakthroughs and future directions in the treatment of hematological malignancies

Guest Editors:
Ajay Abraham: Northwestern University, United States
Ahmet Emre Eşkazan: Istanbul University-Cerrahpaşa, Turkey

Cancer metabolism

Guest Editors:
Elavarasan Subramani: The University of Texas M.D. Anderson Cancer Center, United States
Marija Traikovic-Arsic: German Cancer Consortium, Germany

Cancer control in low- and middle-income countries

Guest Editors:
Cristina StefanInstitute of Global Health Equity Research, Rwanda
Shenglan TangDuke University, United States

Advances in pre-clinical cancer models

Guest Editors:
Ryan C. Fields: Washington University School of Medicine in St. Louis, USA
Anna Golebiewska: Luxembourg Institute of Health, Luxembourg

Extracellular vesicles in cancer progression

Guest Editors:
Orazio Fortunato:
Tumor Genomic Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Italy
Irina Matei: Weill Cornell Medicine, USA
Chunlin Ou: Xiangya Hospital, Central South University, China

Microbiome and cancer - Cross journal collection

Guest editors: Prof. Christopher Staley, Dr. Jacques Ravel and Dr. Sean Devlin. 

Targeted therapies - Cross journal collection

Guest Editors: Prof. Min Li and Dr. Yanis Boumber

Advances in CAR-T immunotherapy - Cross journal collection

Guest Editors: Profs Marko Radic, Djordje Atanackovic and Tim Luetkens


Cross journal collection
Translational Oncology
Guest editor: Prof Tommaso Dragani
Collection published: 28 July 2016


Cross journal collection
Roles of microRNAs and other noncoding RNAs in cancer
Collection published: 26 November 2014


Cross journal collection
Cancer bioinformatics: bioinformatic methods, network biomarkers and precision medicine
Edited by: Xiangdong Wang
Collection published: 1 May 2012


Thematic series
BMC Cancer's 10th anniversary special edition
BMC Cancer
Collection published: 30 November 2011

Annual Journal Metrics

  • Citation Impact 2023
    Journal Impact Factor: 3.4
    5-year Journal Impact Factor: 3.8
    Source Normalized Impact per Paper (SNIP): 0.944
    SCImago Journal Rank (SJR): 1.087

    Speed 2023
    Submission to first editorial decision (median days): 12
    Submission to acceptance (median days): 150

    Usage 2023
    Downloads: 7,974,312
    Altmetric mentions: 3,975

Peer-review Terminology

  • The following summary describes the peer review process for this journal:

    Identity transparency: Single anonymized

    Reviewer interacts with: Editor

    Review information published: Review reports. Reviewer Identities reviewer opt in. Author/reviewer communication

    More information is available here

Sign up for article alerts and news from this journal